PRTCPureTech Health PLC
18.51USD+2.53%Mkt Cap: 419.90M USDP/E: Last update: 2026-05-29

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. It is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmon…

Indicators:|

Key Statistics

Company
Market Cap419.90M USD
Enterprise Value4.14B USD
Revenue (TTM)4.66M USD
Gross Profit-51.80M USD
Net Income (TTM)-109.74M USD
Revenue/Share0.1900 USD
Last Price18.51 USD
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)-34.50
PEG
EV/EBITDA-42.79
EV/Revenue889.38
P/S90.13
P/B1.34
EPS (TTM)-4.60
EPS (Forward)-0.50
52W Range
14.5074% of range19.92
52W High19.92 USD
52W Low14.50 USD
Profitability
Gross Margin0.00%
Oper. Margin-1797.79%
EBITDA Margin0.00%
Profit Margin-2355.42%
ROE-35.16%
ROA-20.52%
Growth
Revenue Growth-38.20%
Earnings Growth
Cash Flow & Leverage
Operating CF-85.13M USD
CapEx (TTM)6.00K USD
FCF Margin-1931.54%
FCF Yield-21.43%
Net Debt-85.46M USD
Net Debt/EBITDA0.88
Balance Sheet
Debt/Equity0.06
Current Ratio6.59
Quick Ratio6.41
Book Value/Sh12.91 USD
Cash/Share1.186 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.24.34M
Float157.18M
Insiders0.00%
Institutions0.58%
Short Interest
Short Ratio3.9d
Short % Float0.12%
Short % Out.0.10%
Shares Short24.52K
Short (prev mo.)14.82K
Technical
SMA 5016.94 (+9.3%)
SMA 20017.21 (+7.5%)
Beta0.79
S&P 52W Chg27.70%
Avg Vol (30d)13.70K
Avg Vol (10d)7.83K
Technical Indicators
RSI (14)55.7
MACD0.2299
MACD Signal0.1466
MACD Hist.+0.0832
BB Upper18.50 USD
BB Middle17.46 USD
BB Lower16.41 USD
BB Width12.02%
ATR (14)0.7326 USD
Vol Ratio (20d)0.07x